Senators Bernie Sanders and Angus King plan to introduce a bill to ban pharmaceutical companies from direct-to-consumer advertising, The Wall Street Journal’s Megan Graham reports. Under the proposed bill, promotional communications targeting consumers would be prohibited, including through TV, radio, print, digital platforms, and social media, and would apply to all prescription drug ads. “The American people don’t want to see misleading and deceptive prescription drug ads on television,” Sanders says. “They want us to take on the greed of the pharmaceutical industry and ban these bogus ads.” Publicly traded companies in the space include AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- JPMorgan biotech/pharma analysts hold analyst/industry conference call
- Johnson & Johnson announces new Phase 1b data on bleximenib
- RFK Jr. names eight members to vaccine panel, WSJ reports
- RFK Jr. names new CDC vaccine advisory panel picks, STAT reports
- Johnson & Johnson reports results from Phase 3b APEX study on TREMFYA